menu
    • menu

    Company profile for Sironax

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sironax is an emerging leader in the discovery and development of transformational therapies that address the root cause of age-related degenerative disease. Today, the majority of treatments for these diseases are palliative, with a focus on alleviating symptoms alone. As pioneers in the science surrounding programmed cell death mechanisms and their connection to age-related degenerative disease

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SironaxChina Flag
    Country
    Country
    China
    Address
    Address
    8-10/F, Building 2, Medical Technology Center, Zhongguancun Life Science Park,...
    Telephone
    Telephone
    +86-10-80765868
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sironax.com.cn/i
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sironax Presents Three Abstracts At Neuroscience 2025
    Sironax Presents Three Abstracts At Neuroscience 2025

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182512/0/en/Sironax-Announces-Three-Abstracts-Selected-for-Presentation-at-Neuroscience-2025.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Sironax Appoints Key Leaders To Drive Global Drug Discovery
    Sironax Appoints Key Leaders To Drive Global Drug Discovery

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3171035/0/en/Sironax-Announces-Key-Leadership-Appointments-to-Advance-Global-Drug-Discovery-and-Development.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    Sironax in 2025 Endpoints 11 List of Top Biotech Startups
    Sironax in 2025 Endpoints 11 List of Top Biotech Startups

    19 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/19/3153269/0/en/Sironax-Named-to-2025-Endpoints-11-List-of-the-Most-Promising-Biotech-Startups.html

    GLOBENEWSWIRE
    19 Sep 2025
    Share Share
    Novartis inks $175M option deal for Sironax’s blood-brain barrier
    Novartis inks $175M option deal for Sironax’s blood-brain barrier

    10 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sironax-grants-novartis-exclusive-option-to-acquire-its-brain-delivery-platform-while-retaining-rights-to-advance-selected-therapeutic-assets-302500323.html

    PR NEWSWIRE
    10 Jul 2025
    Share Share
    X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Partnership
    X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Partnership

    05 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230105005289/en

    BUSINESSWIRE
    05 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search